Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi
- PMID: 17972365
Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi
Abstract
Objective: To determine whether Malawi antiretroviral treatment (ART) clinics providing cotrimoxazole (CTX) prophylaxis had lower early mortality rates compared with clinics not providing CTX.
Methods: Retrospective cohort study of eleven ART clinics in Malawi that were or were not providing CTX. Medical record abstraction was performed for all patients (N = 1295) initiating ART between July 1 and December 15, 2005. At 5 ART sites, CTX was given to patients dosed at 960 mg daily or 480 mg twice a day (according to national guidelines).
Results: When all defaults (patients lost to follow-up for >90 days) were excluded from the analysis, the 6-month mortality rate was 10.7% in patients receiving ART at CTX clinics compared with 18.0% in those not at CTX clinics (6-month mortality risk reduction = 40.7%; P = 0.0013). Kaplan-Meier survival curves for patients receiving CTX and patients not receiving CTX were significantly different; survival differences were apparent as early as 40 to 45 days after initiation of ART.
Conclusions: Patients receiving ART in Malawi at clinics offering CTX prophylaxis had significantly reduced mortality during the first 6 months of ART. This additional intervention may have the potential to improve the lives of patients on ART, because CTX is readily available and relatively inexpensive and can, in principle, be easily introduced into ART delivery programs.
Similar articles
-
Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.Curr HIV Res. 2014;12(5):359-65. doi: 10.2174/1570162x1205141121102155. Curr HIV Res. 2014. PMID: 25426939 Free PMC article.
-
TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.Trials. 2016 Jul 18;17(1):322. doi: 10.1186/s13063-016-1392-3. Trials. 2016. PMID: 27431995 Free PMC article. Clinical Trial.
-
Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.J Infect Dis. 2017 Jan 1;215(1):88-94. doi: 10.1093/infdis/jiw495. Epub 2016 Oct 25. J Infect Dis. 2017. PMID: 28077587 Free PMC article. Clinical Trial.
-
Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.Bull World Health Organ. 2012 Feb 1;90(2):128C-138C. doi: 10.2471/BLT.11.093260. Epub 2011 Oct 24. Bull World Health Organ. 2012. PMID: 22423164 Free PMC article. Review.
-
[Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009].Presse Med. 2011 Jul-Aug;40(7-8):e338-57. doi: 10.1016/j.lpm.2010.11.02. Epub 2011 Feb 3. Presse Med. 2011. PMID: 21295437 Review. French.
Cited by
-
Initiation of anti-retroviral/Trimethoprim-Sulfamethoxazole therapy in a longitudinal cohort of HIV-1 positive individuals in Western Kenya rapidly decreases asymptomatic malarial parasitemia.Front Cell Infect Microbiol. 2022 Nov 24;12:1025944. doi: 10.3389/fcimb.2022.1025944. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36506016 Free PMC article.
-
Factors Affecting Adherence to Co-Trimoxazole Preventive Therapy in HIV/AIDS Patients Attending an Antiretroviral Therapy Clinic in Ethiopia University Hospital: A Cross-Sectional Study.Patient Prefer Adherence. 2020 May 22;14:881-890. doi: 10.2147/PPA.S252805. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32546982 Free PMC article.
-
Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013.PLoS One. 2019 Apr 23;14(4):e0215776. doi: 10.1371/journal.pone.0215776. eCollection 2019. PLoS One. 2019. PMID: 31013320 Free PMC article.
-
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.PLoS One. 2018 Dec 31;13(12):e0206907. doi: 10.1371/journal.pone.0206907. eCollection 2018. PLoS One. 2018. PMID: 30596666 Free PMC article. Clinical Trial.
-
Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.Malar J. 2017 Oct 6;16(1):403. doi: 10.1186/s12936-017-2047-x. Malar J. 2017. PMID: 28985732 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical